Rein Therapeutics Inc (RNTX)

Finanzdaten der Rein Therapeutics Inc-Aktie (RNTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	16.18%6.08	5.23	32.66	5.49	6.87
Research and Development	18.39%3.64	3.07	2.00	1.68	4.29
Operating Income/Loss	16.18%-6.08	-5.23	-32.66	-5.49	-6.87
	9.20%-6.38	-5.84	-31.97	-5.58	-6.82
Attributable To Parent	9.20%-6.38	-5.84	-31.97	-5.58	-6.82
Basic Average Shares	121.00%67.08	30.35	-	26.36	24.19
Diluted Average Shares	121.00%67.08	30.35	-	26.36	24.19
Basic Earnings Per Share	47.37%-0.10	-0.19	-	-0.21	-0.28
Diluted Earnings Per Share	47.37%-0.10	-0.19	-	-0.21	-0.28
Common Stock Dividends	-	-	-	-	-